Fixed-dose combination
Citric acid, Dextrose and Sodium citrate, unspecified form is a fixed-dose combination of an anti-coagulant, a calculi dissolution agent and an osmotic laxative. MedsAcross supplies Citric acid, Dextrose and Sodium citrate, unspecified form for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is an anticoagulant intended for use only with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. See the device operator's manual for additional information and complete usage instructions.
Source: US FDA prescribing information
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A acts as an extracorporeal anticoagulant by binding the free calcium in the blood. Calcium is a necessary co-factor to several steps in the clotting cascade. The following ingredients are key components of the solution: Citric acid for pH regulation Sodium Citrate for anticoagulation Dextrose for isotonicity This solution has no pharmacological effect.
Source: US FDA prescribing information
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is added to blood products collected for extracorporeal processing. ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A may only be used with devices that prepare Platelet Rich Plasma (PRP) products for extracorporeal use. For instructions on the use of the solution see the device operator's manual. Follow the directions for drawing ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A into a syringe for further processing of the collected blood product.
Source: US FDA prescribing information
NOT FOR PREPARATION OF BLOOD PRODUCTS FOR TRANSFUSION OR FOR DIRECT INTRAVENOUS INFUSION.
Source: US FDA prescribing information
Do not use the ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A unless the solution is clear and the container is intact and undamaged. Do not transfer the solution bag directly into the sterile field. Do not reuse. Discard unused or partially used solution bags. Discard the product if the Needleless Access Valve (NAV) does not function as intended. Aseptically prepare the NAV before use. Use aseptic technique throughout all procedures to ensure donor safety and quality.
Source: US FDA prescribing information
Citrate reactions or toxicity may occur with the injection of blood products containing citrate anticoagulant. The recipient of the blood product containing citrate should be monitored for the signs and symptoms of citrate toxicity. The signs and symptoms of citrate toxicity begin with paresthesia, a "tingling" sensation around the mouth or in the extremities, followed by severe reactions that are characterized by hypotension and possible cardiac arrhythmia. Citrate toxicity may occur more frequently in patients who are hypothermic, have impaired liver or renal function, or have low calcium levels because of an underlying disease.
Source: US FDA prescribing information
Store up to 25 °C. Protect from freezing. Protect from direct sunlight.
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
3 presentations of Citric acid, Dextrose and Sodium citrate, unspecified form, sorted by availability.
| Medicine | Active ingredient | Manufacturer | Register | Availability |
|---|---|---|---|---|
| Acd A 6 g/18.375 g/16.5 g per 750 mL injectionIntravenous | Citric acid, Dextrose and Sodium citrate, unspecified form | Terumo BCT | US FDA | Available on request |
| Anticoagulant Citrate Dextrose (ACD-A) 0.4 g/1.225 g/1.1 g per 50 mL injectionIntravenous | Citric acid, Dextrose and Sodium citrate, unspecified form | Terumo BCT | US FDA | Available on request |
| Citric acid, Dextrose and Sodium citrate, unspecified form 0.4 g/1.225 g/1.1 g per 50 mL injectionExtracorporealGeneric name | Citric acid, Dextrose and Sodium citrate, unspecified form | — | US FDA | Available on request |
2 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | Not recorded | — |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Yes, on request. MedsAcross lists 3 presentations of Citric acid, Dextrose and Sodium citrate, unspecified form and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 2 brand names for Citric acid, Dextrose and Sodium citrate, unspecified form, including Acd A, Anticoagulant Citrate Dextrose (ACD-A).
No listed presentation of Citric acid, Dextrose and Sodium citrate, unspecified form is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.